Search research articles
Contact Us
Filters
Showing results (321-330 of 973) with videos related to
Page
of 98
Sort By:
Antiviral Therapy
|
May 16, 2019
Pre-treatment antiviral resistance in Australians with chronic hepatitis C: prevalence of NS3 and NS5A resistance data in the state of New South Wales
Adrian Tl Ong, Enoch Tay, Dominic E Dwyer, et al.
Clinical Epidemiology
|
January 18, 2018
Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia
Monica C Robotin, Ximena Masgoret, Mamta Porwal, et al.
International Journal of Molecular Medicine
|
July 7, 2009
Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis
Nghi Phung, Natasha Pera, Geoffrey Farrell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 16, 2013
Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review
Victoria A Sublette, Mark W Douglas, Kirsten McCaffery, et al.
Cancer Medicine
|
February 23, 2026
Palliative Care Admission at End-of-Life in Liver Cancer: A 10 Year Population-Based Study of 3565 Deaths in Australia
Rebecca J Mitchell, Shenghan Cai, Jacob George, et al.
Journal of Health Psychology
|
September 30, 2016
Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion
Victoria A Sublette, Sian K Smith, Jacob George, et al.
Bulletin of the World Health Organization
|
May 20, 2014
Community-based prevention of hepatitis-B-related liver cancer: Australian insights
Monica C Robotin, Melanie Q Kansil, Mamta Porwal, et al.
Plos One
|
March 27, 2015
Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury
Christopher Scott, Kuan Cha, Renuka Rao, et al.
Frontiers in Cardiovascular Medicine
|
June 20, 2022
The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review
Soloman Saleh, Jacob George, Katharine A Kott, et al.
Biology
|
October 27, 2022
Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy
Michael Fassler, Sagi Tshori, Yaron Barac, et al.
Page
of 98
Search research articles
Search
Showing results (321-330 of 973) with videos related to
Sort By:
Page
of 98
Antiviral Therapy
|
May 16, 2019
Pre-treatment antiviral resistance in Australians with chronic hepatitis C: prevalence of NS3 and NS5A resistance data in the state of New South Wales
Adrian Tl Ong, Enoch Tay, Dominic E Dwyer, et al.
Clinical Epidemiology
|
January 18, 2018
Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia
Monica C Robotin, Ximena Masgoret, Mamta Porwal, et al.
International Journal of Molecular Medicine
|
July 7, 2009
Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis
Nghi Phung, Natasha Pera, Geoffrey Farrell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 16, 2013
Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review
Victoria A Sublette, Mark W Douglas, Kirsten McCaffery, et al.
Cancer Medicine
|
February 23, 2026
Palliative Care Admission at End-of-Life in Liver Cancer: A 10 Year Population-Based Study of 3565 Deaths in Australia
Rebecca J Mitchell, Shenghan Cai, Jacob George, et al.
Journal of Health Psychology
|
September 30, 2016
Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion
Victoria A Sublette, Sian K Smith, Jacob George, et al.
Bulletin of the World Health Organization
|
May 20, 2014
Community-based prevention of hepatitis-B-related liver cancer: Australian insights
Monica C Robotin, Melanie Q Kansil, Mamta Porwal, et al.
Plos One
|
March 27, 2015
Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury
Christopher Scott, Kuan Cha, Renuka Rao, et al.
Frontiers in Cardiovascular Medicine
|
June 20, 2022
The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review
Soloman Saleh, Jacob George, Katharine A Kott, et al.
Biology
|
October 27, 2022
Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy
Michael Fassler, Sagi Tshori, Yaron Barac, et al.
Page
of 98